PHARMAFORM
Turnover is estimated at about €320,000, probably between €190,000 and €600,000.
Balance sheet
balance sheet total €471,917 on 31-12-2013in euro
in euro
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|
| 53,070 | 72,322 | 83,147 | 32,073 | 35,571 | 81,484 | 61,945 | -46,861 | ||
| 36,171 | 78,242 | 65,562 | 12,280 | 15,243 | 54,106 | 34,143 | -59,649 | ||
| 32,900 | 13,467 | 0 | 0 | 0 | 0 | 0 | 525,000 | ||
| -4,786 | -11,216 | 16,801 | 312 | -3,646 | - | - | - | ||
| -24,750 | 7,146 | 50,027 | 17,344 | 35,607 | 51,118 | -33,451 | -45,639 | ||
| 16.5% | 16.1% | 4.1% | -3.6% | -0.8% | 1.3% | -6.2% | -7.7% | ||
| 0.79 | 1.08 | 1.47 | 1.20 | 1.79 | 2.87 | 0.40 | 0.04 | ||
| 5.08 | 5.23 | 23.48 | - | - | 73.51 | - | - | ||
| 2.1% | 71.9% | 183.9% | - | - | 395.6% | - | - | ||
| 0.3% | 11.5% | 7.5% | -2.8% | -2.2% | 5.3% | 1.6% | -17.7% |
EBIT margin not included in this filing.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||||
20/58 |
471,917 | 473,415 | 523,212 | 496,957 | 500,567 | 524,712 | 494,990 | 500,751 | |
21/28 |
379,708 | 381,370 | 367,500 | 393,750 | 420,000 | 446,250 | 472,500 | 498,750 | |
22/27 |
379,708 | 381,370 | 367,500 | 393,750 | 420,000 | 446,250 | 472,500 | 498,750 | |
22 |
357,774 | 381,370 | 367,500 | 393,750 | 420,000 | 446,250 | 472,500 | 498,750 | |
23 |
4,600 | - | - | - | - | - | - | 0 | |
24 |
17,334 | - | - | - | - | - | - | - | |
29/58 |
92,209 | 92,045 | 155,712 | 103,207 | 80,567 | 78,462 | 22,490 | 2,001 | |
40/41 |
91,053 | 86,103 | 138,554 | 98,850 | 80,522 | 74,771 | 22,490 | 2,001 | |
40 |
24,737 | 51,103 | 49,533 | 19,828 | 0 | 12,700 | - | - | |
41 |
66,316 | 35,000 | 89,021 | 79,022 | 80,522 | 62,071 | 22,490 | 2,001 | |
54/58 |
1,156 | 5,942 | 17,158 | 357 | 45 | 3,691 | - | 0 | |
490/1 |
- | - | - | 4,000 | - | - | - | - | |
| Balance sheet: equity and liabilities | |||||||||
10/49 |
471,917 | 473,415 | 523,212 | 496,957 | 500,567 | 524,712 | 494,990 | 500,751 | |
10/15 |
77,631 | 76,022 | 21,377 | -17,935 | -3,965 | 7,042 | -30,814 | -38,706 | |
10/11 |
70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 60,000 | 60,000 | |
100 |
70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | 70,000 | |
101 |
- | - | - | - | - | 0 | 10,000 | 10,000 | |
13 |
1,497 | 1,497 | 1,497 | 1,497 | 1,497 | 1,497 | 1,497 | 1,497 | |
130 |
1,497 | 1,497 | 1,497 | 1,497 | 1,497 | 1,497 | 1,497 | 1,497 | |
14 |
6,134 | 4,525 | -50,120 | -89,432 | -75,462 | -64,455 | -92,311 | -100,204 | |
17/49 |
394,286 | 397,393 | 501,835 | 514,892 | 504,532 | 517,670 | 525,803 | 539,458 | |
17 |
277,327 | 312,494 | 395,841 | 428,372 | 459,572 | 490,325 | 466,814 | 491,817 | |
170/4 |
277,327 | 312,494 | 395,841 | 428,372 | 459,572 | 490,325 | 466,814 | 491,817 | |
42/48 |
116,959 | 84,899 | 105,685 | 85,863 | 44,960 | 27,345 | 55,941 | 47,641 | |
42 |
35,167 | 33,564 | 32,532 | 31,200 | 29,880 | 26,489 | 25,003 | 23,742 | |
43 |
- | - | - | - | - | - | 3 | 6 | |
430/8 |
- | - | - | - | - | 0 | 3 | 6 | |
44 |
19,273 | 18,438 | 10,353 | - | 9,324 | - | 529 | - | |
440/4 |
19,273 | 18,438 | 10,353 | - | 9,324 | 0 | 529 | - | |
45 |
13,028 | 3,667 | 15,037 | 1,445 | - | - | - | - | |
450/3 |
13,028 | 3,667 | 15,037 | 1,445 | - | - | - | - | |
47/48 |
49,491 | 29,230 | 47,763 | 53,218 | 5,756 | 856 | 30,406 | 23,893 | |
492/3 |
- | - | 309 | 657 | - | 0 | 3,049 | 0 | |
| Income statement | |||||||||
76A |
- | 24,000 | - | - | - | - | - | - | |
9900 |
123,797 | 79,810 | 90,656 | 39,115 | 43,655 | 90,642 | 69,163 | 20,943 | |
630 |
34,562 | 23,597 | 26,250 | 26,250 | 26,250 | 26,250 | 26,250 | 28,886 | |
631/4 |
58,000 | - | - | - | - | - | - | - | |
640/8 |
12,727 | 7,488 | 7,509 | 7,042 | 8,084 | 9,157 | 7,218 | 67,804 | |
66A |
- | - | - | - | - | - | 0 | 240 | |
9901 |
18,508 | 48,725 | 56,897 | 5,823 | 9,321 | 55,234 | 35,695 | -75,747 | |
75/76B |
6 | 316 | 10 | - | 9 | 10 | 13 | 6 | |
75 |
6 | 316 | 10 | - | 9 | 10 | 13 | 6 | |
65/66B |
16,886 | 17,095 | 17,594 | 19,793 | 20,337 | 27,387 | 27,812 | 12,554 | |
65 |
16,886 | 17,095 | 17,594 | 19,793 | 20,337 | 27,387 | 27,812 | 12,554 | |
9903 |
1,628 | 55,946 | 39,313 | -13,970 | -11,007 | 27,857 | 7,896 | -88,535 | |
67/77 |
19 | 1,301 | 1 | - | 0 | 1 | 3 | 1 | |
9904 |
1,609 | 54,645 | 39,312 | -13,970 | -11,007 | 27,856 | 7,893 | -88,535 | |
9905 |
1,609 | 54,645 | 39,312 | -13,970 | -11,007 | 27,856 | 7,893 | -88,535 | |
| Appropriation of the result | |||||||||
9906 |
6,134 | 4,525 | -50,120 | -89,432 | -75,462 | -64,455 | -92,311 | -100,204 | |
| Document | |||||||||
The accounts for 4 older financial years, from 2002 to 2005, were filed as documents without figures as data, scans for example.
Source: Annual accounts 2013 (PDF), filed on 25-08-2014.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2013 | full format | 25-08-2014 | 2014-46300592 | |
| 31-12-2012 | full format | 28-08-2013 | 2013-51100428 | |
| 31-12-2011 | full format | 28-08-2012 | 2012-47600005 | |
| 31-12-2010 | full format | 18-11-2011 | 2011-61300143 | |
| 31-12-2009 | abbreviated format | 31-08-2010 | 2010-50200287 | |
| 31-12-2008 | abbreviated format | 26-06-2009 | 2009-31500294 | |
| 31-12-2007 | abbreviated format | 20-06-2008 | 2008-26800353 | |
| 31-12-2006 | abbreviated format | 11-07-2007 | 2007-39500297 | |
| 31-12-2005 | full format | 31-08-2006 | 2006-76202026 | |
| 31-12-2004 | full format | 06-09-2005 | 2005-66703684 | |
| 31-12-2003 | full format | 05-10-2004 | 2004-71101789 | |
| 31-12-2002 | full format | 22-09-2003 | 2003-68201339 |
Insights on PHARMAFORM
The operating result for 2013 is 62% lower than in 2012 and the lowest since 2010. It is the second fall in a row.
Debt's share of the balance-sheet total falls from 83.9% to 83.5%. Equity is higher and debt is lower.